Professor Chris Mason is internationally recognized to be at the forefront of the emerging field of stem cell and regenerative medicine translation and commercialization. A background in basic science, clinical medicine, bioprocessing and business allows Chris a unique insight and understanding of the challenges facing the regen sector as it grows into a competitive and sustainable global healthcare industry.

Chris holds a Clinical Sciences degree from Imperial College London, a Medical degree from the United Medical and Dental Schools of Guy’s and St. Thomas’s Hospitals (now King’s College London) and a PhD under the supervision of Prof. Peter Dunnill in tissue-engineering bioprocessing from University College London.

Following graduation, Chris specialized in surgery and is a Fellow of the Royal College of Surgeons both of England and in Ireland. Today, after a transition from clinical practice to research, he holds a Personal Chair in Regenerative Medicine Bioprocessing, leads the Regenerative Medicine Bioprocess Group in the Advanced Centre for Biochemical Engineering at UCL and is on the Steering Committee for the UCL Centre for Stem Cells and Regenerative Medicine. Other accomplishments include; being Senior Editor of "Regenerative Medicine" journal, co-founder and a Director of the London Regenerative Medicine Network (LRMN) and on the founding Steering Committee for the UK National Stem Cell Network (UKNSCN).

Chris is also on a number of national and international committees, working groups and initiatives related to the academic, clinical and commercial advancement of cell therapies and tissue engineering. For example, he has broad range of expertise in commercial consultancy and is presently on the Scientific Advisory Boards of a number of regen companies based in North America and also led the UK government sponsored “Advanced Cells and Tissue Therapy Global Watch Mission” to the USA in 2006.